Evidence map›Paper›PMID 31752995›Full record

ArticleBiology of sex differences2019

Female sex, high soluble CD163, and low HDL-cholesterol were associated with high galectin-3 binding protein in type 1 diabetes.

Eva Olga Melin, Jonatan Dereke, Magnus Hillman

Open access · goldAbstract read
In one paragraph

Article in Biology of sex differences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Galectin-3-binding protein and future venous thromboembolism.Research and practice in thrombosis and haemostasis · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eva Olga MelinDiabetes Research Laboratory, Lund University, Lund, Sweden. eva.melin@kronoberg.se.ORCID 0000-0002-7835-2650
Jonatan DerekeDiabetes Research Laboratory, Lund University, Lund, Sweden.
Magnus HillmanDiabetes Research Laboratory, Lund University, Lund, Sweden.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGalectin-3 binding protein (Gal3BP), sCD163, galectin-3, and depression have been linked to cardiovascular disease and mortality. In patients with type 1 diabetes, female sex has also been linked to cardiovascular disease and mortality. The aim was to explore whether female sex, sCD163, galectin-3, and depression were associated with Gal3BP in patients with type 1 diabetes. We adjusted for metabolic variables, creatinine, smoking, physical inactivity, and cardiovascular disease.

methodsCross-sectional design. Patients with type 1 diabetes (n = 285, women 44%, age18-59 years, diabetes duration 1-55 years) were consecutively recruited from one diabetes outpatient clinic. Blood samples, anthropometrics, and blood pressure were collected, supplemented with data from electronic medical records. High Gal3BP was defined as ≥3.3 mg/l (≥80th percentile). Depression was assessed by a self-report instrument. Linear and logistic regression models were elaborated for the associations and calibrated and validated for goodness of fit with the data variables.

resultsMedian (q

conclusionsHigh Gal3BP levels were associated with female sex, increasing sCD163 and total cholesterol levels, and decreasing HDL-cholesterol levels in patients with type 1 diabetes. The prevalence of high Gal3BP was more than twice as high in the women as in the men.

Indexed as

Sex CharacteristicsAdolescentAdultAntidepressive AgentsAntigens, CDAntigens, Differentiation, MyelomonocyticAntigens, NeoplasmAntihypertensive AgentsBiomarkers, TumorBlood ProteinsCD163 AntigenCholesterol, HDLDepressionDiabetes Mellitus, Type 1Extracellular Matrix ProteinsFemaleAntidepressive AgentsAntigens, CDAntigens, Differentiation, MyelomonocyticAntigens, NeoplasmAntihypertensive AgentsBiomarkers, TumorBlood ProteinsCD163 AntigenCholesterol, HDLExtracellular Matrix ProteinsGalectin 3GalectinsHypolipidemic AgentsInsulinLGALS3BP protein, humanLGALS3 protein, humanReceptors, Cell SurfaceBiomarkersDepressionGalectin-3Galectin-3 binding proteinHDL-cholesterolInflammationsCD163Sex differencesType 1 diabetes

Identifiers

PMID31752995
PMCPMC6868807
OpenAlexW2990065877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.